BTC used to be an uncorrelated asset, but that’s no longer the case. What can gold and stocks suggest about the crypto markets? Bitcoin (BTC) is...
Wednesday’s policy meeting was supposed to be a non-event. The Federal Reserve was widely expected to leave interest rates pinned near zero while the central bank...
One of major elements of the American Rescue Plan (ARP), signed into law on March 11, was a one-year expansion of the Child Tax Credit (CTC). The...
Top 10 penny stocks to watch right now? Check these out for your list
Copper prices have been trending higher in recent years. What was the highest price for copper and when did the red metal hit that point? The...
Life sciences conglomerate Danaher Corp. $DHR has struck a deal to buy the fast-growing Aldevron, one of the world’s top manufacturers of hotly sought-after plasmid DNA,...
Beijing Retaliates After EU Excludes China-Made Vaccines From Digital COVID 'Passport' Authored by Alex Wu via The Epoch Times, The European Union will start its “EU...
Anglo American’s [AAL-LSE] De Beers Group unit, Debswana Diamond Company, and the government of Botswana announced the discovery of a 1,098-carat diamond believed to be...
TORONTO – Most Canadians have not set aside anything for retirement in the past year (63%) which is up 5% since last year, according to the...
CRANBROOK – According to BC Check-Up: Live, an annual report by the Chartered Professional Accountants of British Columbia (CPABC) on demographic and affordability trends across...
Findings may lead to new therapies for necrotizing enterocolitis Credit: Matt Miller/Washington University The intestinal disease necrotizing enterocolitis is a leading cause of death among premature...
The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development The post White House pledges $3 billion war...
The dollar index rose 0.53% at 91.892, its highest since mid April The dollar…
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it's better for individuals to mix what's available.
Vaccines have successfully curtailed viral diseases for decades. But as COVID-19 vaccination hesitancy shows, mistrust and misinformation continue to put lives at risk.
During the pandemic, researchers have treated Twitter as a sprawling and evolving historical document.
Coinbase Custody will be used to further secure the cryptocurrency holdings of iTrustCapital clients. Cryptocurrency IRA and 401(k) provider iTrustCapital has integrated Coinbase Custody into its...
Mortgage applications for new home sales fell 9% month-over-month in May at a seasonally unadjusted pace ― the second consecutive month sales of new homes have...
German biotech CureVac NV said the company's Covid-19 vaccine was only 47 percent effective in a late-stage trial, missing the study’s main goal and throwing in...
Washington D.C.-based global science and technology innovator Danaher announced a definitive agreement to acquire Aldevron for $9.6 billion.
Pfizer Inc.'s oral rheumatoid arthritis drug Xeljanz reduced death or respiratory failure in hospitalized Covid-19 patients with pneumonia in Brazil, meeting the study's main goal.
A senior Chinese epidemiologist said the United States should be the priority in the next phase of investigations into the origin of Covid-19 after a study...
Slam in sales, but signs of recovery What was COVID-19’s damage in Bulgaria, Poland, and Romania? The first six months of the pandemic claimed a quarter...
Hello friends and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.
The post-pandemic return to work will provide an opportunity for employers and employees to reconsider relationships. Here’s how organizations can build morale and stop valued employees...
The Delta variant: What it is, where it came from, why it's different and whether COVID-19 vaccines can prevent it.
Life sciences conglomerate Danaher Corp. $DHR has struck a deal to buy the fast-growing Aldevron, one of the world’s top manufacturers of hotly sought-after plasmid DNA,...
It’s harvest day for a pair of biotech startups with lofty goals to break new ground in cancer and coronary heart disease — and their high-profile...
The day after CureVac revealed its mRNA vaccine failed a pivotal trial, crushing the company’s stock, a group of analysts tuned into the company call with...
CureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its COVID-19 vaccine candidate failed to achieve its endpoints...